Overview

Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients

Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy and safety of colistin versus lactulose for secondary prophylaxis of overt hepatic encephalopathy in patients with liver cirrhosis.
Phase:
Early Phase 1
Details
Lead Sponsor:
Madonna Magdy Fahmy
Treatments:
Colistin
Lactulose